Blood sugar can improve while insulin resistance drivers remain
doi:10.1136/gut.12.2.164.[Crossref], [PubMed], [Web of Science ] , [Google Scholar]) furthered their earlier work by administering 5% PGN to guinea pigs in their drinking water for 2045 days
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment
CrossRef Differential Modulation by Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) of Mesenteric Fat and Macrophages and T Cells in Adipose Tissue of Obese fa/fa Zucker Rats Lena Hong, Peter Zahradka, Carla G
The AWARD-7 trial shows that the glucagon-like peptide 1 (GLP1) receptor agonist dulaglutide, which is not cleared by the kidney, seems to be renoprotective, ameliorates albuminuria and slows estimated glomerular filtration rate decline in patients with type 2 diabetes mellitus and chronic kidney disease, without increasing the risk of hypoglycaemia
Dynamic clonal equilibrium and predetermined cancer risk in Barretts oesophagus